Skip to content

Disruptions of the day-night rhythm after treatment for a non-functioning pituitary adenoma; a cross-sectional study using actigraphy.

Disruptions of the day-night rhythm after treatment for a non-functioning pituitary adenoma; a cross-sectional study using actigraphy. - Actigraphy in NFMA patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39636
Enrollment
250
Registered
2012-12-06
Start date
2013-04-04
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-functioning pituitary adenoma non-hormone producing adenoma of the pituitary gland

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Informed consent Mentally competent Age 18-70 years NFMA patients: treated for non-functioning pituitary macroadenoma, adequate substitution of any hormone deficiencies for at least 4 months. Documented adenopituitary deficiencies. Hypocortisol patients: treatment for primary adrenal gland insufficiency or bilateral adrenalectomy, adequate substitution of cortisol for at least 4 months.

Exclusion criteria

Exclusion criteria: Pregnancy Diagnosted sleeping disorder Diseases of the hypothalamus or pituitary gland other that NFMA Chronic use of sleep medication or sedative medication Age >70 years

Design outcomes

Primary

MeasureTime frame
Registration of day-night rhythmicity and objective sleep duration using actigraphy and sleep diaries

Secondary

MeasureTime frame
Quality of life and subjective sleep quality

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)